On Tuesday the situation in Italy consolidated with growth in net active cases for Italy as a whole staying low at 3% (Monday 2%). Despite this we expect the recovery to strengthen significantly over the coming days, which should bring Italy to a peak this week. In Germany, as anticipated, net active cases returned to growth as the daily recovery…
European Covid-19 Tracking Update
A financial market resource for the every-day investor and trader.
-
Earnings Review: Target’s 3rd Quarter Beats Overshadow Negative Sales Growth
Seth Golden, , Research Reports, 0
Last week, Target Corp. (TGT) reported stronger than expected earnings and revenues. This sent shares of TGT higher as...
-
J.C. Penney Is Optimistic Despite Lowering Sales Expectations
Seth Golden, , Research Reports, 0
J.C. Penney (JCP) reported less than expected top-line growth for the Q3 2016 period while reporting in-line EPS expectations. Last week,...
-
Analysts Commentary From Around Financial Markets
Seth Golden, , Research Reports, 0
Burgeoning ‘green shoots’ bring hope for an economic recovery The last time I used the term “green shoots” was...
-
Equity Markets Look For Balance Amidst Trade War And Reflation Fears
Seth Golden, , Research Reports, 0
This week is likely to prove a considerably important week as equity markets have gyrated back and forth throughout...
-
Value Squeeze: J.P. Morgan Team
Seth Golden, , Research Reports, 0
US Equity Strategy Style Positioning, Value Squeeze, Winner Takes All Rising odds of a sharp Value squeeze in the...
-
Lead Biotech Analysts Updates Vaccine Forecast
Seth Golden, , Research Reports, 0
Pfizer has not yet accrued the32 COVID infections for its 1st interim analysis: The fact that Pfizer’s first interim...
-
Weekly State of the Market: Growth vs. Value & Markets vs. Economy
Seth Golden, , Research Reports, 0
Some 90% of RIAs can’t analyze markets with any proficiency! Some 90% of analysts can’t advise clients in a...
-
2021 Opportunity, But Not Before Another Shakeout
Seth Golden, , Research Reports, 0
Investors are increasingly embracing the recovery. We laid out our bullish 12 month view in our 2021 Outlook (Show...
Recent Articles
Featured Products
- JPM Market Recap $0.00
- JPM Research Note $0.00
- JP Morgan Market Volatility Report $0.00
Comments are closed.